. Direct comparison of mass cytometry and flow cytometry gating strategies to identify human B cell subsets Table S1 . Mass cytometry antibody panel for B cell phenotyping Table S2 . Purity of FACS-sorted intestinal ASCs and MBCs used for Elispot and qRT-PCR Table S3 . V gene segment usage among VP6-specific intestinal ASCs isolated using DLP-Cy5 (Table S1 ) or fluorescently labeled antibody panels for analysis by mass cytometry or flow cytometry, respectively. Shown are representative 2D mass cytometry and flow cytometry dot plots (100,000 events acquired per sample) from a single donor depicting the gating strategy used and the frequencies of subsets as determined by CyTOF and FACS. Cells were washed with complete RPMI and rested for 2 h at 37 ºC and 5% CO 2 prior to mass cytometry staining with the metal-tagged antibody panel listed in Table S1 . Shown are mass cytometry histogram overlays of the expression of each cell surface marker on total PBMCs with and without liberase treatment. At least 100, 000 events were acquired per sample. 
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